Skip to main content
Beijing SL Pharmaceutical Co., Ltd. logo

Beijing SL Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002038 ISIN · CNE000001L31 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,472 across all filing types
Latest filing 2019-04-23 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002038

About Beijing SL Pharmaceutical Co., Ltd.

https://www.slpharm.com.cn

Beijing SL Pharmaceutical Co., Ltd. specializes in the research, development, manufacturing, and commercialization of pharmaceutical products. The company focuses on several therapeutic areas, including cardiovascular and cerebrovascular diseases, oncology, and infectious diseases. Its product portfolio features a range of chemical drugs and active pharmaceutical ingredients (APIs), with key offerings such as clopidogrel bisulfate and amlodipine besylate. Operating with advanced production facilities that adhere to international Good Manufacturing Practice (GMP) standards, the company emphasizes technological innovation and quality control. The organization serves both domestic and international markets, leveraging its integrated R&D platform to develop generic medications and innovative formulations aimed at improving patient outcomes.

Recent filings

Filing Released Lang Actions
2018年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an "审计报告" (Audit Report) for Beijing Shuanglu Pharmaceutical Co., Ltd. It includes detailed auditor opinions, audit basis, key audit matters, and extensive financial statements such as consolidated balance sheet, income statement, cash flow statement, and equity changes for the fiscal year ending December 31, 2018. The presence of an auditor's opinion, detailed audit procedures, and comprehensive financial statements indicates this is a standalone audit report rather than a full annual report or other filing. The document length is substantial (15,000 characters), and it contains the full audit report and financial statements, not just an announcement or certification. Therefore, the correct classification is Audit Report / Information (AR). FY 2018
2019-04-23 Chinese
关于控股子公司在全国中小企业股份转让系统终止挂牌的公告
Delisting Announcement Classification · 100% confidence The document is an official announcement from Beijing SL Pharmaceutical Co., Ltd. regarding the termination of listing of its controlling subsidiary on the National SME Share Transfer System. It includes specific dates of board and shareholder meetings approving the delisting, references to regulatory filings, and the formal consent letter from the exchange. The document is short (957 characters) and focuses on the delisting event rather than financial results or other report types. Therefore, it fits the definition of a Delisting Announcement (DLST).
2019-04-02 Chinese
关于第二大股东减持计划实施完成的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the completion of a shareholding reduction plan by the company's second largest shareholder. It details the number of shares reduced, the methods used, the timeline, and compliance with relevant stock exchange rules. There is no financial report, earnings data, or management discussion. The content fits the definition of a Major Shareholding Notification, as it reports changes in significant share ownership levels.
2019-03-18 Chinese
关于控股子公司拟申请在全国中小企业股份转让系统终止挂牌的提示性公告
Delisting Announcement Classification · 100% confidence The document is a short announcement (808 characters) regarding the intention of a controlling subsidiary to apply for delisting from the National Equities Exchange and Quotations (NEEQ), also known as the 'New Third Board' in China. It details board and shareholder meeting approvals related to the delisting application and notes that the delisting is subject to regulatory approval. The document does not contain financial statements or detailed financial data, nor is it a full report. It is an official notice about a stock delisting event. Therefore, it fits the definition of a Delisting Announcement (DLST).
2019-03-14 Chinese
关于第二大股东减持计划实施进展的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the progress of a major shareholder's share reduction plan. It details the number of shares reduced, the methods of reduction, and compliance with relevant stock exchange rules. It does not contain financial statements or performance data, nor is it a report or presentation. It is a regulatory announcement about shareholding changes by a significant shareholder, fitting the category of Major Shareholding Notification (MRQ). The document length is short and focused on shareholding changes, not a full report or earnings release.
2019-03-05 Chinese
2018年度业绩快报
Earnings Release Classification · 95% confidence The document is titled as a 2018 annual performance quick report (业绩快报) from Beijing SL Pharmaceutical Co., Ltd. It contains preliminary financial data for the year 2018, including revenue, profit, net profit, earnings per share, and asset information. The text explicitly states that the data is preliminary, internally audited but not audited by an accounting firm, and may differ from the final annual report. The document is relatively short (1421 characters) and serves as an initial earnings summary rather than a full annual report. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. It is not a full Annual Report (10-K) or Interim Report (IR) because it lacks comprehensive financial statements and detailed analysis. It is not a Report Publication Announcement (RPA) because it contains actual financial data, not just a notice of report availability. FY 2018
2019-02-27 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.